Ask Our Doctors – Archive

Our Medical Directors are outstanding physicians that you will find to be very personable and compassionate, who take care to ensure that you have the most cutting-edge fertility treatments at your disposal. This is your outlet to ask your questions to the doctors.

19,771 Comments

  1. 1. Why all of our embryos got arrested on day 5? (we did each cycle in a different clinic)

    A: Respectfully, I would not just assume that the arrest was due to sperm issue. It could also have been an egg issue related to the protocol used for ovarian stimulation and its implementation (see below).

    2. Should I do sperm aspiration while I have more than enough sperm for ICSI in the ejaculate?

    A: Respectfully, I do not believe that testicular aspiration has merit when there are viable sperm in the ejaculate.

    3. What do you recommend for our case?

    A complete review/revision of the protocol used for ovarian stimulation and PGS testing of all blastocysts with subsequent Staggered FET of PGS-normal blastocysts. In addition, it is imperative at the same time, to rule out an anatomical or immunologic implantation dysfunction (IID)…see below.

    I strongly recommend that you visit http://www.DrGeoffreySherIVF.com. Then go to my Blog and access the “search bar”. Type in the titles of any/all of the articles listed below, one by one. “Click” and you will immediately be taken to those you select. Please also take the time to post any questions or comments with the full expectation that I will (as always) respond promptly.
    •The IVF Journey: The importance of “Planning the Trip” Before Taking the Ride”
    •Controlled Ovarian Stimulation (COS) for IVF: Selecting the ideal protocol
    •IVF: Factors Affecting Egg/Embryo “competency” during Controlled Ovarian Stimulation(COS)
    •The Fundamental Requirements For Achieving Optimal IVF Success
    •Ovarian Stimulation for IVF using GnRH Antagonists: Comparing the Agonist/Antagonist Conversion Protocol.(A/ACP) With the “Conventional” Antagonist Approach
    •Anti Mullerian Hormone (AMH) Measurement to Assess Ovarian Reserve and Design the Optimal Protocol for Controlled Ovarian Stimulation (COS) in IVF.
    •Staggered IVF: An Excellent Option When. Advancing Age and Diminished Ovarian Reserve (DOR) Reduces IVF Success Rate
    •Embryo Banking/Stockpiling: Slows the “Biological Clock” and offers a Selective Alternative to IVF-Egg Donation
    •Preimplantation Genetic Testing (PGS) in IVF: It should be Used Selectively and NOT be Routine.
    •IVF: Selecting the Best Quality Embryos to Transfer
    •Preimplantation Genetic Sampling (PGS) Using: Next Generation Gene Sequencing (NGS): Method of Choice.
    •PGS in IVF: Are Some Chromosomally abnormal Embryos Capable of Resulting in Normal Babies and Being Wrongly Discarded?
    •PGS and Assessment of Egg/Embryo “competency”: How Method, Timing and Methodology Could Affect Reliability
    •IVF: The first Choice for Infertile Women 40 to 43 Years of Age!
    •IVF Failure and Implantation Dysfunction:
    •The Role of Immunologic Implantation Dysfunction (IID) & Infertility (IID):PART 1-Background
    •Immunologic Implantation Dysfunction (IID) & Infertility (IID):PART 2- Making a Diagnosis
    •Immunologic Dysfunction (IID) & Infertility (IID):PART 3-Treatment
    •Thyroid autoantibodies and Immunologic Implantation Dysfunction (IID)
    •Immunologic Implantation Dysfunction: Importance of Meticulous Evaluation and Strategic Management:(Case Report
    •Intralipid and IVIG therapy: Understanding the Basis for its use in the Treatment of Immunologic Implantation Dysfunction (IID)
    •Intralipid (IL) Administration in IVF: It’s Composition; How it Works; Administration; Side-effects; Reactions and Precautions
    •Natural Killer Cell Activation (NKa) and Immunologic Implantation Dysfunction in IVF: The Controversy!
    •Endometrial Thickness, Uterine Pathology and Immunologic Factors
    •Vaginally Administered Viagra is Often a Highly Effective Treatment to Help Thicken a Thin Uterine Lining
    •Treating Out-of-State and Out-of-Country Patients at Sher-IVF in Las Vegas:
    •A personalized, stepwise approach to IVF
    •Male Factor Infertility
    •Routine Fertilization by Intracytoplasmic Sperm Injection (ICSI): An Argument in Favor
    •Hormonal Treatment of Male Infertilit
    •Antisperm Antibodies, Infertility and the Role of IVF with Intracytoplasmic Sperm Injection (ICSI)
    •Testicular Sperm Extraction (TESE) and Testicular Sperm Aspiration (TESA): Surgical Approaches for Accessing Sperm from men who have no sperm in their ejaculates (Azoospermia)
    •Varicocele and Male Infertility: When and how should it be treated?
    •The Sperm Chromatin Structure Assay (SCSA): A Measure of the Potential of Sperm to Help Propagate a Viable Pregnancy

    Please call or email Julie Dahan, my patient concierge. She will guide you on how to set up an in-person or Skype consultation with me. You can reach Julie at on her cell phone or via email at any time:
    Julie Dahan
    •Email: Julied@sherivf.com
    •Phone: 702-533-2691
    ?800-780-7437

    Geoff Sher

    I also suggest that you access the 4th edition of my book ,”In Vitro Fertilization, the ART of Making Babies”. It is available as a down-load through http://www.Amazon.com or from most bookstores and public libraries.

  2. Dear Doctor, we are really devastated and feeling no meaning in life after our Blastocyst transfer failed.Doctor said it was of good quality and he has inserted 3 embryos(5days frozen blastocyst) and hcg after 14days was 21 and then it did not improve much. Doctor has asked us to do hysteroscopy if we are trying again and we are disappointed…from your expereince can you tell us the reasons? even if we do this test, you think it is something curable? we are really devastated….please help

    • Try not to be so down on yourselves. It could be bad luck, but then usually there is a reason for the failure.

      Whenever a patient fails to achieve a viable pregnancy following embryo transfer (ET), the first question asked is why! Was it simply due to, bad luck?, How likely is the failure to recur in future attempts and what can be done differently, to avoid it happening next time?.
      It is an indisputable fact that any IVF procedure is at least as likely to fail as it is to succeed. Thus when it comes to outcome, luck is an undeniable factor. Notwithstanding, it is incumbent upon the treating physician to carefully consider and address the causes of IVF failure before proceeding to another attempt:
      1.Age: The chance of a woman under 35Y of age having a baby per embryo transfer is about 35-40%. From there it declines progressively to under 5% by the time she reaches her mid-forties. This is largely due to declining chromosomal integrity of the eggs with advancing age…”a wear and tear effect” on eggs that are in the ovaries from birth.
      2.Embryo Quality/”competency (capable of propagating a viable pregnancy)”. As stated, the woman’s age plays a big role in determining egg/embryo quality/”competency”. This having been said, aside from age the protocol used for controlled ovarian stimulation (COS) is the next most important factor. It is especially important when it comes to older women, and women with diminished ovarian reserve (DOR) where it becomes essential to be aggressive, and to customize and individualize the ovarian stimulation protocol.
      We used to believe that the uterine environment is more beneficial to embryo development than is the incubator/petri dish and that accordingly, the earlier on in development that embryos are transferred to the uterus, the better. To achieve this goal, we used to select embryos for transfer based upon their day two or microscopic appearance (“grade”). But we have since learned that the further an embryo has advanced in its development, the more likely it is to be “competent” and that embryos failing to reach the expanded blastocyst stage within 5-6 days of being fertilized are almost invariably “incompetent” and are unworthy of being transferred. Moreover, the introduction into clinical practice about a decade ago, (by Levent Keskintepe PhD and myself) of Preimplantation Genetic Sampling (PGS), which assesses for the presence of all the embryos chromosomes (complete chromosomal karyotyping), provides another tool by which to select the most “competent” embryos for transfer. This methodology has selective benefit when it comes to older women, women with DOR, cases of unexplained repeated IVF failure and women who experience recurrent pregnancy loss (RPL).
      3.The number of the embryos transferred: Most patients believe that the more embryos transferred the greater the chance of success. To some extent this might be true, but if the problem lies with the use of a suboptimal COS protocol, transferring more embryos at a time won’t improve the chance of success. Nor will the transfer of a greater number of embryos solve an underlying embryo implantation dysfunction (anatomical molecular or immunologic).Moreover, the transfer of multiple embryos, should they implant, can and all too often does result in triplets or greater (high order multiples) which increases the incidence of maternal pregnancy-induced complications and of premature delivery with its serious risks to the newborn. It is for this reason that I rarely recommend the transfer of more than 2 embryos at a time and am moving in the direction of advising single embryo transfers …especially when it comes to transferring embryos derived through the fertilization of eggs from young women.
      4.Implantation Dysfunction (ID): Implantation dysfunction is a very common (often overlooked) cause of “unexplained” IVF failure. This is especially the case in young ovulating women who have normal ovarian reserve and have fertile partners. Failure to identify, typify, and address such issues is, in my opinion, an unfortunate and relatively common cause of repeated IVF failure in such women. Common sense dictates that if ultrasound guided embryo transfer is performed competently and yet repeated IVF attempts fail to propagate a viable pregnancy, implantation dysfunction must be seriously considered. Yet ID is probably the most overlooked factor. The most common causes of implantation dysfunction are:
      a.A“ thin uterine lining”
      b.A uterus with surface lesions in the cavity (polyps, fibroids, scar tissue)
      c.Immunologic implantation dysfunction (IID)
      d.Endocrine/molecular endometrial receptivity issues
      Certain causes of infertility are repetitive and thus cannot readily be reversed. Examples include advanced age of the woman; severe male infertility; immunologic infertility associated with alloimmune implantation dysfunction (especially if it is a “complete DQ alpha genetic match between partners plus uterine natural killer cell activation (NKa).
      I strongly recommend that you visit http://www.DrGeoffreySherIVF.com. Then go to my Blog and access the “search bar”. Type in the titles of any/all of the articles listed below, one by one. “Click” and you will immediately be taken to those you select. Please also take the time to post any questions or comments with the full expectation that I will (as always) respond promptly.
      •The IVF Journey: The importance of “Planning the Trip” Before Taking the Ride”
      •Controlled Ovarian Stimulation (COS) for IVF: Selecting the ideal protocol
      •IVF: Factors Affecting Egg/Embryo “competency” during Controlled Ovarian Stimulation(COS)
      •The Fundamental Requirements For Achieving Optimal IVF Success
      •Ovarian Stimulation for IVF using GnRH Antagonists: Comparing the Agonist/Antagonist Conversion Protocol.(A/ACP) With the “Conventional” Antagonist Approach
      •Ovarian Stimulation in Women Who have Diminished Ovarian Reserve (DOR): Introducing the Agonist/Antagonist Conversion protocol
      •Anti Mullerian Hormone (AMH) Measurement to Assess Ovarian Reserve and Design the Optimal Protocol for Controlled Ovarian Stimulation (COS) in IVF.
      •Human Growth Hormone Administration in IVF: Does it Enhances Egg/Embryo Quality and Outcome?
      •The BCP: Does Launching a Cycle of Controlled Ovarian Stimulation (COS). Coming off the BCP Compromise Response?
      •Blastocyst Embryo Transfers Should be the Standard of Care in IVF
      •IVF: How Many Attempts should be considered before Stopping?
      •“Unexplained” Infertility: Often a matter of the Diagnosis Being Overlooked!
      •IVF Failure and Implantation Dysfunction:
      •The Role of Immunologic Implantation Dysfunction (IID) & Infertility (IID):PART 1-Background
      •Immunologic Implantation Dysfunction (IID) & Infertility (IID):PART 2- Making a Diagnosis
      •Immunologic Dysfunction (IID) & Infertility (IID):PART 3-Treatment
      •Thyroid autoantibodies and Immunologic Implantation Dysfunction (IID)
      •Immunologic Implantation Dysfunction: Importance of Meticulous Evaluation and Strategic Management:(Case Report
      •Intralipid and IVIG therapy: Understanding the Basis for its use in the Treatment of Immunologic Implantation Dysfunction (IID)
      •Intralipid (IL) Administration in IVF: It’s Composition; How it Works; Administration; Side-effects; Reactions and Precautions
      •Natural Killer Cell Activation (NKa) and Immunologic Implantation Dysfunction in IVF: The Controversy!
      •Endometrial Thickness, Uterine Pathology and Immunologic Factors
      •Vaginally Administered Viagra is Often a Highly Effective Treatment to Help Thicken a Thin Uterine Lining
      •Treating Out-of-State and Out-of-Country Patients at Sher-IVF in Las Vegas:
      •A personalized, stepwise approach to IVF
      •How Many Embryos should be transferred: A Critical Decision in IVF.
      •The Role of Nutritional Supplements in Preparing for IVF

      Please call or email Julie Dahan, my patient concierge. She will guide you on how to set up an in-person or Skype consultation with me. You can reach Julie at on her cell phone or via email at any time:
      Julie Dahan
      •Email: Julied@sherivf.com
      •Phone: 702-533-2691
      ?800-780-7437

      Geoff Sher

      I also suggest that you access the 4th edition of my book ,”In Vitro Fertilization, the ART of Making Babies”. It is available as a down-load through http://www.Amazon.com or from most bookstores and public libraries.

  3. Sorry Doc. Forgot to mention, repeated the HCG test on 22/12 . Level was at 131

  4. Hi Doc. On 15/12 I had a HCG test done after my 2nd IUI. Level was at 64 & my dr confirmed I was pregnant. I’ve had slight bleeding on 21/12 which seems to be increasing in amount but no pains. Dr has put me on utrogestan & advised on bed rest. Going in for an ultrasound on 28/12 . should I start accepting that this means that a miscarriage is a strong possibility?

    • Sadly Meshnee, this does not look promising given your beta hCG level of 131MIU/ml on 12/21.

      So sorry…I really hope I am wrong though!

      Geoff Sher

  5. Hi Dr. Sher –

    I just finished my first (unsuccessful) IVF cycle yesterday, which was supposed to be my transfer day, and after talking with my doctor, she is suspecting the problem is due to the fact that I’m a low responder.

    I’m 32 with an AMH of 2.15 ng/ml and (as I have been told) I have a normal antrafollicle count and FSH level. During other (normal, non-IVF) cycles of mine, they have counted anywhere between 11 to 19 follicles during ultrasounds. So my doc says she’s perplexed as to why my response was so low. I am doing IVF /ICSI due to a male infertility factor (low motility). I have just sent you an email of the overview of my IVF cycle, but here are the details:

    – long Lupron cycle: 20 units for 10 days, then 10 units when I started to stem
    – Baseline E2 was 35.8
    – Day 4 of stems, E2 was only 34.9, so they increased me from 225 IU Menopur (what I was taking up until this day) to 150IU Menopur and 300 IU Follistim
    – Day 6 of stems, E2 was 63.8 and 1 follicle that was 6.9
    – Day 8 of stems, E2 was 162 and 4 follicles at 13.03, 10.2, 9.53, and 15.03
    – Day 10 of stems, E2 was 328 and 10 follicles at 12.8, 12.1, 11.47, 5.6, 9.2, 7.3, 17.43, 8.3, 5.77, 8.27
    – Day 11 of stems, E2 was 379 and still 10 follicles, with 4 of them over 13 (15.23, 13.97, 14.27, 18.7)
    – Day 12 of stems, E2 was 631 and 14 folllicles, with 4 of them over 13 (16.2, 14.3, 15.23, 17.27)
    – Day 13, I only took 420 HCG

    So during my egg retrieval, they counted 6 eggs: two of them GV, one Atr (Partho), three MII, but one of the MII had 2 polar bodies, and the other MII was atretic. The third MII was normal and had a normal fertilization with ICSI, but the embryo did not get past the 6 cell stage and was deteriorating on day 5 (yesterday).

    I am wondering your thoughts on my case – am I a low responder, despite “normal” AMH, ovarian reserve and antrifollicle count? Does it also appear that I have an egg quality issue? If I should pursue IVF again, what stimulation method or drug combination would you recommend?

    Thank you so much for your help!

    – distraught and concerned

    • Hi Holly,

      I might be able to help here. At 1st glace, it seems that your ovarian reserve is normal (AMH/AFC). Thus you should respond far better. However, in my opinion, you need a more aggressive initial push. I would start on a much higher dosage of FSHr (Follistim) and would add human growth hormone to the mix. I would also switch to an agonist/antagonist conversion protocol and would undertake embryo banking of PGS biopsied embryos.

      Please visit my new Blog on this very site, https://www.drgeoffreysherivf.com, find the “search bar” and type in the titles of any/all of the articles listed below, one by one. “Click” and you will immediately be taken to those you select. Please also take the time to post any questions or comments with the full expectation that I will (as always) respond promptly.

      • Controlled Ovarian Stimulation (COS) for IVF: Selecting the ideal protocol
      • IVF: Factors Affecting Egg/Embryo “competency” during Controlled Ovarian Stimulation(COS)
      • The Fundamental Requirements For Achieving Optimal IVF Success
      • Ovarian Stimulation for IVF using GnRH Antagonists: Comparing the Agonist/Antagonist Conversion Protocol.(A/ACP) With the “Conventional” Antagonist Approach
      • Anti Mullerian Hormone (AMH) Measurement to Assess Ovarian Reserve and Design the Optimal Protocol for Controlled Ovarian Stimulation (COS) in IVF.
      • The “Biological Clock” and how it should Influence the Selection and Design of Ovarian Stimulation Protocols for IVF.
      • A Rational Basis for selecting Controlled Ovarian Stimulation (COS) protocols in women with Diminished Ovarian Reserve (DOR)
      • Diagnosing and Treating Infertility due to Diminished Ovarian Reserve (DOR)
      • Controlled Ovarian Stimulation (COS) in Older women and Women who have Diminished Ovarian Reserve (DOR): A Rational Basis for Selecting a Stimulation Protocol
      • Human Growth Hormone Administration in IVF: Does it Enhances Egg/Embryo Quality and Outcome?
      • The BCP: Does Launching a Cycle of Controlled Ovarian Stimulation (COS). Coming off the BCP Compromise Response?
      • Blastocyst Embryo Transfers should be the Standard of Care in IVF
      • Frozen Embryo Transfer (FET) versus “Fresh” ET: How to Make the Decision
      • Frozen Embryo Transfer (FET): A Rational Approach to Hormonal Preparation and How new Methodology is Impacting IVF.
      • Staggered IVF: An Excellent Option When. Advancing Age and Diminished Ovarian Reserve (DOR) Reduces IVF Success Rate
      • Embryo Banking/Stockpiling: Slows the “Biological Clock” and offers a Selective Alternative to IVF-Egg Donation.
      • Preimplantation Genetic Testing (PGS) in IVF: It should be Used Selectively and NOT be Routine.
      • Preimplantation Genetic Sampling (PGS) Using: Next Generation Gene Sequencing (NGS): Method of Choice.
      • PGS in IVF: Are Some Chromosomally Abnormal Embryos Capable of Resulting in Normal Babies and Being Wrongly Discarded?
      • PGS and Assessment of Egg/Embryo “competency”: How Method, Timing and Methodology Could Affect Reliability
      • Treating Out-of-State and Out-of-Country Patients at Sher-IVF in Las Vegas:
      • Traveling for IVF from Out of State/Country–
      • A personalized, stepwise approach to IVF
      • How Many Embryos should be transferred: A Critical Decision in IVF.
      • The Role of Nutritional Supplements in Preparing for IVF
      • Premature Luteinization (“the premature LH surge): Why it happens and how it can be prevented.
      • IVF Egg Donation: A Comprehensive Overview

      I invite you to arrange to have a Skype or an in-person consultation with me to discuss your case in detail. If you are interested, please contact Julie Dahan, at:
      Email: Julied@sherivf.com
      OR
      Phone: 702-533-2691
      800-780-7437
      I also suggest that you access the 4th edition of my book ,”In Vitro Fertilization, the ART of Making Babies”. It is available as a down-load through http://www.Amazon.com or from most bookstores and public libraries.